https://neptunecorp.com/wp-content/uploads/2019/10/NEPT-PR-IFF-partnership-Version-6.pdf
“IFF is a well-recognized leader and innovator in taste, scent, nutrition and ingredients and we could not be more excited at the potential of combining the resources of our two organizations to develop plant-based consumer products, including hemp-derived CBD products. The formulation and technological expertise that IFF cumulates will greatly benefit Neptune in accelerating its market penetration in the U.S. CBD market. This partnership aligns well with our growth strategy of expanding core customers and of supporting consumer packaged goods companies and fragrance houses’ expansion into the CBD market,” said Michael Cammarata, CEO of Neptune.
About Neptune Wellness Solutions Inc.
Neptune Wellness Solutions specializes in the extraction, purification and formulation of health and wellness products. Neptune’s wholly owned subsidiary, 9354-7537 Québec Inc., is licensed by Health Canada to process cannabis at its 50,000-square-foot facility located in Sherbooke, Quebec. With the recent acquisition of SugarLeaf, the Company now has a U.S.-based hemp extract supply chain supported by a 24,000 square-foot facility located in North Carolina. Neptune and SugarLeaf combined bring decades of experience in the natural products sector to the legal cannabis and hemp industry. Leveraging its scientific and technological expertise, The Company as a whole focuses on the development of value-added and differentiated products for the Canadian, U.S. and global cannabis and hemp markets. Neptune’s activities also include the development and commercialization of turnkey nutrition solutions and patented ingredients such as MaxSimil®, and a variety of marine and seed oils. Its head office is located in Laval, Quebec.
Forward Looking Statements
Statements in this press release that are not statements of historical or current fact constitute “forward-looking statements” within the meaning of the U.S. securities laws and Canadian securities laws. Such forward-looking statements involve known and unknown risks, uncertainties, and other unknown factors that could cause the actual results of Neptune to be materially different from historical results or from any future results expressed or implied by such forward-looking statements. In addition to statements which explicitly describe such risks and uncertainties, readers are urged to consider statements labeled with the terms "believes", "belief", "expects", "intends", “projects”, "anticipates", "will", "should" or "plans," or which refer to expectations, projections or other characterizations of future events or circumstances, to be uncertain and forward-looking. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this press release.
The forward-looking statements contained in this press release are expressly qualified in their entirety by this cautionary statement and the “Cautionary Note Regarding Forward-Looking
2 of 2
Information” section contained in Neptune’s latest Annual Information Form (the “AIF”), which also forms part of Neptune’s latest annual report on Form 40-F, and which is available on SEDAR at www.sedar.com, on EDGAR at www.sec.gov/edgar.html and on the investor section of Neptune’s website at www.neptunecorp.com. All forward-looking statements in this press release are made as of the date of this press release. Neptune does not undertake to update any such forward-looking statements whether as a result of new information, future events or otherwise, except as required by law. The forward-looking statements contained herein are also subject generally to other risks and uncertainties that are described from time to time in Neptune’s public securities filings with the Securities and Exchange Commission and the Canadian securities commissions. Additional information about these assumptions and risks and uncertainties is contained in the AIF under “Risk Factors”. Neither NASDAQ nor the Toronto Stock Exchange accepts responsibility for the adequacy or accuracy of this release.
Investor Information:
Pierre Boucher
MaisonBrison
1.514.731.0000
pierre@maisonbrison.com
Media Request:
Sabrina Di Blasio
Neptune Wellness Solutions
514.258.8183
s.diblasio@neptunecorp.com
Recent NEPT News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/30/2024 04:01:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/12/2024 09:02:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/27/2024 08:42:52 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/12/2024 08:22:53 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/06/2024 10:15:01 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/06/2024 04:04:07 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/16/2024 10:20:41 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 02/15/2024 10:16:35 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 01/02/2024 07:02:04 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/05/2023 03:05:36 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/30/2023 10:26:53 PM
- Neptune Wellness Nutraceutical Brand, Biodroga, Announces Accounts Receivable Factoring Facility of Up to $8 Million • PR Newswire (US) • 11/29/2023 01:30:00 PM
- Neptune Wellness Nutraceutical Brand, Biodroga, Announces Accounts Receivable Factoring Facility of Up to $8 Million • PR Newswire (Canada) • 11/29/2023 01:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/27/2023 02:14:35 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/24/2023 09:42:50 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/21/2023 09:59:26 PM
- Neptune Wellness Announces Letter of Intent to Acquire Leading Data-Marketing and Artificial Intelligence Company, Datasys, for Total Potential Consideration of $112 Million • PR Newswire (Canada) • 11/20/2023 01:00:00 PM
- Neptune Wellness Announces Letter of Intent to Acquire Leading Data-Marketing and Artificial Intelligence Company, Datasys, for Total Potential Consideration of $112 Million • PR Newswire (US) • 11/20/2023 01:00:00 PM
- Neptune Reports Fiscal Second Quarter 2024 Financial Results • PR Newswire (Canada) • 11/14/2023 10:59:00 PM
- Neptune Reports Fiscal Second Quarter 2024 Financial Results • PR Newswire (US) • 11/14/2023 10:59:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/13/2023 09:01:19 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/13/2023 02:57:12 PM
- Neptune Wellness Announces Completion of Sprout Organic's Debt Equitization • PR Newswire (Canada) • 11/08/2023 02:57:00 PM
- Neptune Wellness Announces Completion of Sprout Organic's Debt Equitization • PR Newswire (US) • 11/08/2023 02:57:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/30/2023 03:16:29 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM